Companies /Healthcare

Gilead Sciences Inc

NASDAQ: GILD Drug Manufacturers - General
$146.61
▼ $4.38 (−2.90%) today
Markets open · 1:58pm ET

Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
100%
EPS beat rate
+5.74%
Avg. EPS surprise
Consecutive EPS beats
GILD vs Market · 30-day return after each reportGILDS&P 500
−5%0%+5%+5.1%+6.7%Q1 25−3.5%+2.4%Q2 25+4.4%+0.3%Q3 25−6.8%−3.3%Q4 25−7.5%−1.7%Q1 26
−5%0%+5%Q1 25Q2 25Q3 25Q4 25Q1 26
GILD EPS Trend · estimate vs actualEstimateActual
$0.00$0.70$1.40$2.10$1.77$1.81Q1 25$1.96$2.01Q2 25$2.14$2.47Q3 25$1.83$1.86Q4 25$1.91$2.03Q1 26
$0.00$0.70$1.40$2.10Q1 25Q2 25Q3 25Q4 25Q1 26
GILD Revenue Trend · estimate vs actualEstimateActual
$0$3.0B$6.0B$6.8B$6.7BQ1 25$7.0B$7.1BQ2 25$7.5B$7.8BQ3 25$7.7B$7.9BQ4 25$6.9B$7.0BQ1 26
$0$3.0B$6.0BQ1 25Q2 25Q3 25Q4 25Q1 26

Quarter by Quarter

Quarter EPS · est. Surprise Revenue · est. Surprise
Q1 2026 $2.03 est. $1.91 +6.30% $7.0B est. $6.9B +0.51%
Q4 2025 $1.86 est. $1.83 +1.88% $7.9B est. $7.7B +3.21%
Q3 2025 $2.47 est. $2.14 +15.67% $7.8B est. $7.5B +4.14%
Q2 2025 $2.01 est. $1.96 +2.72% $7.1B est. $7.0B +1.69%
Q1 2025 $1.81 est. $1.77 +2.11% $6.7B est. $6.8B −2.14%

Figures from SEC filings and company reports. Not investment advice.